For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Gems #85
Wednesday 15 August 2018, 12:30 AM
“Primary care weight loss study put almost half in remission from diabetes”
In a randomised controlled trial of a weight management programme, 46% of 306 participants were in remission from their diabetes at 1 year (HbA1c <48m
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References